Page last updated: 2024-09-23

tetraphenylcyclopentadienone

Description

tetraphenylcyclopentadienone: singlet oxygen trapping agent [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID68068
CHEMBL ID4534655
CHEBI ID188913
SCHEMBL ID516326
MeSH IDM0054146

Synonyms (59)

Synonym
tetraphenylcyclopentadienone
tetracyclone
2, 2,3,4,5-tetraphenyl-
2,4,5-tetraphenylcyclopentadienone
tetraphenyl-2,4-cyclopentadien-1-one
479-33-4
tetracyclon
cyclone (compound)
nsc-2060
cyclone
nsc2060
2,4,5-tetraphenyl-2,4-cyclopentadienone
nsc243761
nsc220314
nsc-220314
nsc-243761
2,3,4,5-tetraphenylcyclopenta-2,4-dien-1-one
inchi=1/c29h20o/c30-29-27(23-17-9-3-10-18-23)25(21-13-5-1-6-14-21)26(22-15-7-2-8-16-22)28(29)24-19-11-4-12-20-24/h1-20
2,4-cyclopentadien-1-one, 2,3,4,5-tetraphenyl-
STK363114
GHL.PD_MITSCHER_LEG0.162
tetraphenylcyclopentadienone, 98%
OPREA1_165374
2,3,4,5-tetraphenylcyclopenta-2,4-dienone
AKOS000813949
2,3,4,5-tetraphenyl-2,4-cyclopentadien-1-one
AC-907/25014396
T1062
CHEBI:188913
A7317
einecs 207-530-3
2,3,4,5-tetraphenylcyclopentadienone
unii-e8ct23p8wp
nsc 2060
ai3-22092
2,3,4,5-tetraphenyl-2,4-cyclopentadienone
e8ct23p8wp ,
FT-0609356
F9995-0440
c29h20o
AB01331940-02
SCHEMBL516326
tetraphenylcyclopenta-dienone
DTXSID1060059
Q-101911
2,3,4,5-tetraphenyl-2,4-cyclopentadien-1-one #
mfcd00001407
NCGC00341026-01
Q2661932
BBL100010
AMY42106
D70532
CHEMBL4534655
tetraphenyl cyclopentadienone
CS-0072157
cyclopentadienone, tetraphenyl-
EN300-265719
tetraphenylcyclopenta-2,4-dien-1-one
SY048438

Drug Classes (1)

ClassDescription
stilbenoidAny olefinic compound characterised by a 1,2-diphenylethylene backbone.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1640018Luciferase/luciferin-expressing antifolate-resistant parasites were used to infect a culture of HepG2 cells that were pre-incubated with compounds. Infected hepatocytes emit light due to the luciferase reaction. Assay results are presented as the percent 2018Science (New York, N.Y.), 12-07, Volume: 362, Issue:6419
Open-source discovery of chemical leads for next-generation chemoprotective antimalarials.
AID1640019Luciferase/luciferin-expressing antifolate-resistant parasites were used to infect a culture of HepG2 cells that were pre-incubated with compounds. Infected hepatocytes emit light due to the luciferase reaction. Assay results are presented as the percent 2018Science (New York, N.Y.), 12-07, Volume: 362, Issue:6419
Open-source discovery of chemical leads for next-generation chemoprotective antimalarials.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]